Gene Expression Profiles in Healing and Non-Healing Wound (WHGS1)

This study is currently recruiting participants.
Verified November 2012 by Ohio State University
Sponsor:
Collaborator:
National Healing Corporation
Information provided by (Responsible Party):
Gayle Gordillo, Ohio State University
ClinicalTrials.gov Identifier:
NCT01101854
First received: April 8, 2010
Last updated: November 15, 2012
Last verified: November 2012

April 8, 2010
November 15, 2012
December 2004
December 2020   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01101854 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Gene Expression Profiles in Healing and Non-Healing Wound
Gene Expression Profiles in Healing and Non-Healing Wound.

The purpose of the research is to determine whether there are similar patterns of genes being turned on and/or turned off among people with healing and non-healing wounds.

A single subject will provide 2 tissue samples from a single wound over a 4 week time period and the samples will be categorized as healing versus non-healing responses on the basis of decreased (healing) or increased (non-healing) wound area measurements over the 4-week time period. A chronic wound generally is a wound which shows no signs of significant healing in four weeks or has not healed in eight weeks.

Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

Tissue

Probability Sample

Patients who have chronic wound, wound should be 4 week or more in one place with out heal.

Wounds and Injuries
Not Provided
Healing verses non-healing
1
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
900
December 2020
December 2020   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • i. receiving care at an OSU wound care center, or additional additional IRB approved wound care centers
  • ii.Informed consent obtained from patient by designated study nurse

Exclusion Criteria:

  • i. can't provide informed consent
  • ii. therapeutically anticoagulated
  • iii. pregnant females ( > 30 days since 1st day of last menstrual period)
  • iv. receiving chemotherapy for cancer
Both
18 Years and older
No
Contact: Urmila S Gnyawali, RN 614-366-3515 urmila.gnyawali@osumc.edu
United States
 
NCT01101854
2004H0278
No
Gayle Gordillo, Ohio State University
Ohio State University
National Healing Corporation
Principal Investigator: Gayle Gordillo, MD Ohio State University
Ohio State University
November 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP